Nectar Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-7.2%1-day move

₹10.54

prior close

₹10.60

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.4+0.0-0.1-0.2-7.2-11.8-7.4-5.0-4.6+2.5+14.9+20.0+15.6+8.9

Up moveDown movePending

AI summary

Nectar Lifesciences Limited has informed the stock exchanges that its trading window will remain closed starting April 1, 2026, and will reopen 48 hours after the company declares its financial results for the period ending March 31, 2026. During this period, designated persons (insiders) and their immediate relatives are prohibited from trading in the company's shares. This is a routine compliance filing under SEBI's insider trading regulations, typically done ahead of quarterly or annual results announcements.

Likely market impact

This is a standard regulatory filing and has no direct impact on shareholders or stock price. However, it signals that the company is likely to announce its FY26 annual results soon, which could be a catalyst for price movement depending on the numbers.